Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma.

Li, Xiaomi; Ding, Xiaoyan; Liu, Mei; Wang, Jingyan; Li, Wei; Chen, Jinglong

Li, Xiaomi; Ding, Xiaoyan; Liu, Mei; Wang, Jingyan; Li, Wei; Chen, Jinglong.

Afiliación

Li X; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
Ding X; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
Liu M; Department of Oncology, Beijing You'an Hospital, Capital Medical University, Beijing, People's Republic of China.
Wang J; Department of Interventional Radiology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
Li W; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
Chen J; Department of Cancer Center, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.

Oncologist ; 28(10): e942-e949, 2023 10 03.

Article en En | MEDLINE | ID: mdl-37105140

Asunto(s)

Carcinoma Hepatocelular; Quimioembolización Terapéutica; Neoplasias Hepáticas; Humanos; Persona de Mediana Edad; Pronóstico; Carcinoma Hepatocelular/tratamiento farmacológico; Estudios Retrospectivos; Neoplasias Hepáticas/tratamiento farmacológico

Palabras clave

Lenvatinib; hepatocellular carcinoma; platelet-to-lymphocyte ratio; prognostic model; prognostic nutritional index

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google